Nov 8, 2021 Cellectar Reports Financial Results for the Third Quarter 2021 and Provides a Corporate Update Learn More
Oct 25, 2021 Cellectar Announces Innovative Concierge Service for Patients Participating in Its Clinical Studies Learn More
Sep 22, 2021 Preliminary Data with Iopofosine I-131 in Combination with External Beam Radiation Suggests Safety and Tolerability in Relapsed or Refractory Head and Neck Cancer Learn More